The use of Hydroxychloroquine in the Treatment of COVID-19

被引：1
|
作者：
Tecen-Yucel, Kamer [1 ]
Kara, Emre [1 ]
Demirkan, Kutay [1 ]
Unal, Serhat [2 ]
机构：
[1] Hacettepe Univ, Dept Clin Pharm, Fac Pharm, Ankara, Turkey
[2] Hacettepe Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Ankara, Turkey
来源：
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI | 2020年 / 25卷 / 03期
关键词：
Hydroxychloroquine; COVID-19; VIRAL-INFECTIONS; CHLOROQUINE; PHARMACOKINETICS;
D O I：
10.5578/flora.69845
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
COVID-19 is a newly emerging human infectious disease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) origin described as a pandemic by the World Health Organisation (WHO) on March 11, 2020. There is currently no definitive cure for COVID-19; however, among the many treatment strategies, hydroxychloroquine has been suggested as a potential treatment. The purpose of this article was to review the pharmacological properties and mechanism of COVID-19 treatment with hydroxychloroquine and its potential use on the current COVID-19 pandemic.
引用
收藏
页码：283 / 291
页数：9
相关论文
共 50 条
  • [1] USE OF CHLOROQUINE OR HYDROXYCHLOROQUINE IN TREATMENT OF COVID-19: IS IT ETHICAL?
    Allam, Mohamed Farouk
    Andraous, Fady
    [J]. CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 28 (03) : 246 - 247
  • [2] Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
    Sun, JingKang
    Chen, YuTing
    Fan, XiuDe
    Wang, XiaoYun
    Han, QunYing
    Liu, ZhengWen
    [J]. POSTGRADUATE MEDICINE, 2020, 132 (07) : 604 - 613
  • [3] Hydroxychloroquine in the COVID-19 treatment
    Santiesteban Vazquez, Viana Elina
    Castro Barberena, Adys
    [J]. MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2021, 19 (06): : 898 - 899
  • [4] Hydroxychloroquine and azithromycin as a treatment of COVID-19
    Alice Fanin
    Jessica Calegari
    Anna Beverina
    Silvia Tiraboschi
    [J]. Internal and Emergency Medicine, 2020, 15 : 841 - 843
  • [5] Hydroxychloroquine and azithromycin as a treatment of COVID-19
    Fanin, Alice
    Calegari, Jessica
    Beverina, Anna
    Tiraboschi, Silvia
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (05) : 841 - 843
  • [6] Risks of chloroquine or hydroxychloroquine use for COVID-19
    [J]. Reactions Weekly, 2020, 1808 (1) : 5 - 5
  • [7] Risks of hydroxychloroquine use for COVID-19 prophylaxis
    Sachdeva, Muskaan
    Shah, Monica
    Ziv, Michael
    Leshem, Eyal
    Dodiuk-Gad, Roni P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E73 - E74
  • [8] Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
    Kaur, Amritpal
    Chaudhary, Gaurav
    Singh, Pargat
    Arora, Sandeep
    Kaur, Rajwinder
    [J]. CURRENT DRUG TARGETS, 2021, 22 (13) : 1536 - 1547
  • [9] Rethinking the role of hydroxychloroquine in the treatment of COVID-19
    Meyerowitz, Eric A.
    Vannier, Augustin G. L.
    Friesen, Morgan G. N.
    Schoenfeld, Sara
    Gelfand, Jeffrey A.
    Callahan, Michael V.
    Kim, Arthur Y.
    Reeves, Patrick M.
    Poznansky, Mark C.
    [J]. FASEB JOURNAL, 2020, 34 (05): : 6027 - 6037
  • [10] BET 2: HYDROXYCHLOROQUINE IN THE TREATMENT OF COVID-19
    Howard, Laura
    Baombe, Janos
    Reynard, Charles
    [J]. EMERGENCY MEDICINE JOURNAL, 2020, 37 (07) : 451 - 453
12345